Indication

Agglutinin Disease

1 clinical trial

1 product

Clinical trial

A Phase 3, Pivotal, Open-label, Multicenter Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion

Status: Completed, Estimated PCD: 2021-10-05

Product